Serveur d'exploration sur le patient édenté

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Phenotypic characterization of mononuclear inflammatory cells following equine hydroxyapatitecollagen block grafting in rats

Identifieur interne : 003540 ( Main/Exploration ); précédent : 003539; suivant : 003541

Phenotypic characterization of mononuclear inflammatory cells following equine hydroxyapatitecollagen block grafting in rats

Auteurs : Asim Alsuwaiyan [Arabie saoudite, États-Unis] ; Bing-Yan Wang [États-Unis] ; Robert E. Cohen [États-Unis]

Source :

RBID : ISTEX:67C72338A92EBFE2CC7060DD44D5D17B10DCF1D4

Descripteurs français

English descriptors

Abstract

To measure the inflammatory changes associated with the implantation of an equine hydroxyapatite and collagen-containing block graft (eHAC block) in a rodent model system, an eHAC block graft was implanted subcutaneously in rats. Control groups included saline, turpentine oil, and human mineralized particulate allograft (hMPA). Animals were sacrificed and tissue samples obtained after three days, as well as after 1, 2, 4 and 8 weeks. A panel of immunologic probes was used to identify circulatory monocytic cells (ED1), resident mononuclear phagocytes (ED2), mononuclear phagocytes of lymphoid origin (ED3), expression of Ia antigen (OX6), T-cells (OX19), and B-cells (OX33). Immunocytochemical localization was performed and mononuclear cells localized with each immunologic probe counted. Rat sera obtained after eight weeks were used for nitrocellulose dot-blotting to assess circulating anti-equine immunoglobulins. Statistical analysis was performed using two-way analysis of variance, in conjunction with the Bonferroni correction to account for multiple comparisons. A transient increase in monocytes at 3days and 1 week was observed in all groups, but was significantly higher in the turpentine control (P <0.0001). A significant increase in the numbers of mononuclear cells detected with clones ED2 and ED3 was observed in specimens from the turpentine group, in contrast to the other groups in the 3day to 4 week interval (P <0.0001), as well as within all time periods (P <0.0001). A statistically significant difference in numbers of ED3-positive cells was observed in the hMPA group compared to the saline and the eHAC block groups after one week (P <0.0001). Significantly more OX6-positive cells were observed in the turpentine group, compared to other groups (3days to 1 week P <0.0001). T-lymphocytes were essentially absent except for rats given turpentine (after 1 week). No B-lymphocyte response was found and none of the rats developed systemic anti-equine antibodies. These data indicate that a cellular immune response is not elicited following implantation with the eHAC block graft, which might serve as an alternative material for regenerative therapy.

Url:
DOI: 10.1088/1748-6041/7/6/065005


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Phenotypic characterization of mononuclear inflammatory cells following equine hydroxyapatitecollagen block grafting in rats</title>
<author>
<name sortKey="Alsuwaiyan, Asim" sort="Alsuwaiyan, Asim" uniqKey="Alsuwaiyan A" first="Asim" last="Alsuwaiyan">Asim Alsuwaiyan</name>
</author>
<author>
<name sortKey="Wang, Bing Yan" sort="Wang, Bing Yan" uniqKey="Wang B" first="Bing-Yan" last="Wang">Bing-Yan Wang</name>
</author>
<author>
<name sortKey="Cohen, Robert E" sort="Cohen, Robert E" uniqKey="Cohen R" first="Robert E" last="Cohen">Robert E. Cohen</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:67C72338A92EBFE2CC7060DD44D5D17B10DCF1D4</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1088/1748-6041/7/6/065005</idno>
<idno type="url">https://api.istex.fr/document/67C72338A92EBFE2CC7060DD44D5D17B10DCF1D4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003325</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003325</idno>
<idno type="wicri:Area/Istex/Curation">003325</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A10</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A10</idno>
<idno type="wicri:doubleKey">1748-6041:2012:Alsuwaiyan A:phenotypic:characterization:of</idno>
<idno type="wicri:Area/Main/Merge">003557</idno>
<idno type="wicri:Area/Main/Curation">003540</idno>
<idno type="wicri:Area/Main/Exploration">003540</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Phenotypic characterization of mononuclear inflammatory cells following equine hydroxyapatitecollagen block grafting in rats</title>
<author>
<name sortKey="Alsuwaiyan, Asim" sort="Alsuwaiyan, Asim" uniqKey="Alsuwaiyan A" first="Asim" last="Alsuwaiyan">Asim Alsuwaiyan</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>King Fahd Military Medical Complex, Dhahran</wicri:regionArea>
<wicri:noRegion>Dhahran</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Periodontics and Endodontics, School of Dental Medicine, University at Buffalo, State University of New York, Buffalo, NY</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
<settlement type="city">Buffalo (New York)</settlement>
</placeName>
<orgName type="university">Université d'État de New York à Buffalo</orgName>
</affiliation>
</author>
<author>
<name sortKey="Wang, Bing Yan" sort="Wang, Bing Yan" uniqKey="Wang B" first="Bing-Yan" last="Wang">Bing-Yan Wang</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Periodontics, School of Dentistry, The University of Texas, Health Science Center at Houston, Houston, TX</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cohen, Robert E" sort="Cohen, Robert E" uniqKey="Cohen R" first="Robert E" last="Cohen">Robert E. Cohen</name>
<affiliation wicri:level="4">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Periodontics and Endodontics, School of Dental Medicine, University at Buffalo, State University of New York, Buffalo, NY</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
<settlement type="city">Buffalo (New York)</settlement>
</placeName>
<orgName type="university">Université d'État de New York à Buffalo</orgName>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Biomedical Materials</title>
<idno type="ISSN">1748-6041</idno>
<idno type="eISSN">1748-605X</idno>
<imprint>
<publisher>IOP Publishing</publisher>
<date type="published" when="2012-12">2012-12</date>
<biblScope unit="volume">7</biblScope>
<biblScope unit="issue">6</biblScope>
</imprint>
<idno type="ISSN">1748-6041</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1748-6041</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Allograft</term>
<term>Alsuwaiyan</term>
<term>Alveolar bone reconstruction</term>
<term>Alveolar ridge</term>
<term>Alveolar ridge augmentation</term>
<term>Antibody panel</term>
<term>Augmentation</term>
<term>Autogenous</term>
<term>Autogenous block grafts</term>
<term>Autogenous bone grafts</term>
<term>Biomed</term>
<term>Block graft</term>
<term>Bone augmentation</term>
<term>Bone augmentation procedures</term>
<term>Bone block</term>
<term>Bone defects</term>
<term>Bone formation</term>
<term>Bone regeneration</term>
<term>Bone substitutes</term>
<term>Bonferroni correction</term>
<term>Clin</term>
<term>Clinical evaluation</term>
<term>Clinical results</term>
<term>Connective tissue</term>
<term>Connective tissues</term>
<term>Dako corporation</term>
<term>Demineralized bone allograft</term>
<term>Dent</term>
<term>Dental implant placement</term>
<term>Dental medicine</term>
<term>Donor site</term>
<term>Ehac</term>
<term>Ehac block</term>
<term>Ehac block graft</term>
<term>Ehac block grafts</term>
<term>Ehac block groups</term>
<term>Ehac blocks</term>
<term>Equine</term>
<term>Equine block</term>
<term>Equine hydroxyapatite</term>
<term>Future studies</term>
<term>Graft</term>
<term>Graft materials</term>
<term>Graft sites</term>
<term>Granulomatous response</term>
<term>Histologic evaluation</term>
<term>Histologic study</term>
<term>Hmpa</term>
<term>Hmpa group</term>
<term>Hmpa implantation</term>
<term>Implant</term>
<term>Implantation</term>
<term>Lateral ridge augmentation</term>
<term>Lymphoid organs</term>
<term>Macrophage</term>
<term>Mater</term>
<term>Maxillofac</term>
<term>Mild response</term>
<term>Monocyte</term>
<term>Mononuclear</term>
<term>Mononuclear cells</term>
<term>Mononuclear phagocytes</term>
<term>Negative control</term>
<term>Oral implantol</term>
<term>Oral implants</term>
<term>Oral maxillofac</term>
<term>Other groups</term>
<term>Other time periods</term>
<term>Particulate allograft</term>
<term>Periodontal</term>
<term>Periodontal regeneration</term>
<term>Periodontics</term>
<term>Periodontol</term>
<term>Phenotypic characterization</term>
<term>Positive cells</term>
<term>Primary antibody</term>
<term>Regeneration</term>
<term>Resident macrophages</term>
<term>Ridge defects</term>
<term>Saline administration</term>
<term>Saline group</term>
<term>Saline turpentine hmpa ehac block</term>
<term>Second group</term>
<term>Secondary antibody</term>
<term>Similar pattern</term>
<term>State university</term>
<term>Subcutaneous</term>
<term>Subcutaneous tissue section</term>
<term>Such material</term>
<term>Surgical manipulation</term>
<term>Systematic review</term>
<term>Time material</term>
<term>Time period</term>
<term>Time periods</term>
<term>Tissue distribution</term>
<term>Tissue samples</term>
<term>Tissue section</term>
<term>Transient increase</term>
<term>Turpentine</term>
<term>Turpentine group</term>
<term>Vertical ridge augmentation</term>
<term>Week interval</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Allograft</term>
<term>Alsuwaiyan</term>
<term>Alveolar bone reconstruction</term>
<term>Alveolar ridge</term>
<term>Alveolar ridge augmentation</term>
<term>Antibody panel</term>
<term>Augmentation</term>
<term>Autogenous</term>
<term>Autogenous block grafts</term>
<term>Autogenous bone grafts</term>
<term>Biomed</term>
<term>Block graft</term>
<term>Bone augmentation</term>
<term>Bone augmentation procedures</term>
<term>Bone block</term>
<term>Bone defects</term>
<term>Bone formation</term>
<term>Bone regeneration</term>
<term>Bone substitutes</term>
<term>Bonferroni correction</term>
<term>Clin</term>
<term>Clinical evaluation</term>
<term>Clinical results</term>
<term>Connective tissue</term>
<term>Connective tissues</term>
<term>Dako corporation</term>
<term>Demineralized bone allograft</term>
<term>Dent</term>
<term>Dental implant placement</term>
<term>Dental medicine</term>
<term>Donor site</term>
<term>Ehac</term>
<term>Ehac block</term>
<term>Ehac block graft</term>
<term>Ehac block grafts</term>
<term>Ehac block groups</term>
<term>Ehac blocks</term>
<term>Equine</term>
<term>Equine block</term>
<term>Equine hydroxyapatite</term>
<term>Future studies</term>
<term>Graft</term>
<term>Graft materials</term>
<term>Graft sites</term>
<term>Granulomatous response</term>
<term>Histologic evaluation</term>
<term>Histologic study</term>
<term>Hmpa</term>
<term>Hmpa group</term>
<term>Hmpa implantation</term>
<term>Implant</term>
<term>Implantation</term>
<term>Lateral ridge augmentation</term>
<term>Lymphoid organs</term>
<term>Macrophage</term>
<term>Mater</term>
<term>Maxillofac</term>
<term>Mild response</term>
<term>Monocyte</term>
<term>Mononuclear</term>
<term>Mononuclear cells</term>
<term>Mononuclear phagocytes</term>
<term>Negative control</term>
<term>Oral implantol</term>
<term>Oral implants</term>
<term>Oral maxillofac</term>
<term>Other groups</term>
<term>Other time periods</term>
<term>Particulate allograft</term>
<term>Periodontal</term>
<term>Periodontal regeneration</term>
<term>Periodontics</term>
<term>Periodontol</term>
<term>Phenotypic characterization</term>
<term>Positive cells</term>
<term>Primary antibody</term>
<term>Regeneration</term>
<term>Resident macrophages</term>
<term>Ridge defects</term>
<term>Saline administration</term>
<term>Saline group</term>
<term>Saline turpentine hmpa ehac block</term>
<term>Second group</term>
<term>Secondary antibody</term>
<term>Similar pattern</term>
<term>State university</term>
<term>Subcutaneous</term>
<term>Subcutaneous tissue section</term>
<term>Such material</term>
<term>Surgical manipulation</term>
<term>Systematic review</term>
<term>Time material</term>
<term>Time period</term>
<term>Time periods</term>
<term>Tissue distribution</term>
<term>Tissue samples</term>
<term>Tissue section</term>
<term>Transient increase</term>
<term>Turpentine</term>
<term>Turpentine group</term>
<term>Vertical ridge augmentation</term>
<term>Week interval</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Médecine dentaire</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">To measure the inflammatory changes associated with the implantation of an equine hydroxyapatite and collagen-containing block graft (eHAC block) in a rodent model system, an eHAC block graft was implanted subcutaneously in rats. Control groups included saline, turpentine oil, and human mineralized particulate allograft (hMPA). Animals were sacrificed and tissue samples obtained after three days, as well as after 1, 2, 4 and 8 weeks. A panel of immunologic probes was used to identify circulatory monocytic cells (ED1), resident mononuclear phagocytes (ED2), mononuclear phagocytes of lymphoid origin (ED3), expression of Ia antigen (OX6), T-cells (OX19), and B-cells (OX33). Immunocytochemical localization was performed and mononuclear cells localized with each immunologic probe counted. Rat sera obtained after eight weeks were used for nitrocellulose dot-blotting to assess circulating anti-equine immunoglobulins. Statistical analysis was performed using two-way analysis of variance, in conjunction with the Bonferroni correction to account for multiple comparisons. A transient increase in monocytes at 3days and 1 week was observed in all groups, but was significantly higher in the turpentine control (P <0.0001). A significant increase in the numbers of mononuclear cells detected with clones ED2 and ED3 was observed in specimens from the turpentine group, in contrast to the other groups in the 3day to 4 week interval (P <0.0001), as well as within all time periods (P <0.0001). A statistically significant difference in numbers of ED3-positive cells was observed in the hMPA group compared to the saline and the eHAC block groups after one week (P <0.0001). Significantly more OX6-positive cells were observed in the turpentine group, compared to other groups (3days to 1 week P <0.0001). T-lymphocytes were essentially absent except for rats given turpentine (after 1 week). No B-lymphocyte response was found and none of the rats developed systemic anti-equine antibodies. These data indicate that a cellular immune response is not elicited following implantation with the eHAC block graft, which might serve as an alternative material for regenerative therapy.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Arabie saoudite</li>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
<li>État de New York</li>
</region>
<settlement>
<li>Buffalo (New York)</li>
</settlement>
<orgName>
<li>Université d'État de New York à Buffalo</li>
</orgName>
</list>
<tree>
<country name="Arabie saoudite">
<noRegion>
<name sortKey="Alsuwaiyan, Asim" sort="Alsuwaiyan, Asim" uniqKey="Alsuwaiyan A" first="Asim" last="Alsuwaiyan">Asim Alsuwaiyan</name>
</noRegion>
</country>
<country name="États-Unis">
<region name="État de New York">
<name sortKey="Alsuwaiyan, Asim" sort="Alsuwaiyan, Asim" uniqKey="Alsuwaiyan A" first="Asim" last="Alsuwaiyan">Asim Alsuwaiyan</name>
</region>
<name sortKey="Cohen, Robert E" sort="Cohen, Robert E" uniqKey="Cohen R" first="Robert E" last="Cohen">Robert E. Cohen</name>
<name sortKey="Cohen, Robert E" sort="Cohen, Robert E" uniqKey="Cohen R" first="Robert E" last="Cohen">Robert E. Cohen</name>
<name sortKey="Wang, Bing Yan" sort="Wang, Bing Yan" uniqKey="Wang B" first="Bing-Yan" last="Wang">Bing-Yan Wang</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003540 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003540 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:67C72338A92EBFE2CC7060DD44D5D17B10DCF1D4
   |texte=   Phenotypic characterization of mononuclear inflammatory cells following equine hydroxyapatitecollagen block grafting in rats
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022